Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David E Cohn

Showing results (81-90 of 301) with videos related to

Pageof 31
Sort By:
Gynecologic Oncology|June 10, 2008
Novel perioperative imaging with 18F-FDG PET/CT and intraoperative 18F-FDG detection using a handheld gamma probe in recurrent ovarian cancerDavid E Cohn, Nathan C Hall, Stephen P Povoski, et al.
Gynecologic Oncology|August 16, 2012
Complications after double-barreled wet colostomy compared to separate urinary and fecal diversion during pelvic exenteration: time to change back?Floor J Backes, Brent J Tierney, Eric L Eisenhauer, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|December 20, 2015
Endometrial Cancer Insulin-Like Growth Factor 1 Receptor (IGF1R) Expression Increases with Body Mass Index and Is Associated with Pathologic Extent and PrognosisAmy S Joehlin-Price, Julie A Stephens, Jianying Zhang, et al.
International Journal of Cancer|October 17, 2019
Guideline-concordant endometrial cancer treatment and survival in the Women's Health Initiative Life and Longevity After Cancer studyAshley S Felix, Eric M McLaughlin, Bette J Caan, et al.
Applied Immunohistochemistry & Molecular Morphology : AIMM|December 20, 2007
The mucin expression profile of endometrial carcinoma and correlation with clinical-pathologic parametersCarl Morrison, Kambiz Merati, William L Marsh, et al.
Gynecologic Oncology|January 12, 2017
HDAC10 as a potential therapeutic target in ovarian cancerMuhtadi M Islam, Tapahsama Banerjee, Colin Z Packard, et al.
Gynecologic Oncology|January 13, 2009
Sequential chemotherapy and irradiation in advanced stage endometrial cancer: A Gynecologic Oncology Group phase I trial of doxorubicin-cisplatin followed by whole abdomen irradiationJeffrey M Fowler, William E Brady, Perry W Grigsby, et al.
Cancer|August 8, 2013
Cost effectiveness of alternative strategies for incorporating bevacizumab into the primary treatment of ovarian cancerJason C Barnett, Angeles Alvarez Secord, David E Cohn, et al.
Frontiers in Genetics|January 28, 2021
Deregulation of a <i>Cis</i>-Acting lncRNA in Non-small Cell Lung Cancer May Control HMGA1 ExpressionGreg L Stewart, Adam P Sage, Katey S S Enfield, et al.
Gynecologic Oncology|November 10, 2015
Treatment strategies for stage IB cervical cancer: A cost-effectiveness analysis from Korean, Canadian and U.S. perspectivesJung-Yun Lee, Janice S Kwon, David E Cohn, et al.
Pageof 31

Showing results (81-90 of 301) with videos related to

Sort By:
Pageof 31
Gynecologic Oncology|June 10, 2008
Novel perioperative imaging with 18F-FDG PET/CT and intraoperative 18F-FDG detection using a handheld gamma probe in recurrent ovarian cancerDavid E Cohn, Nathan C Hall, Stephen P Povoski, et al.
Gynecologic Oncology|August 16, 2012
Complications after double-barreled wet colostomy compared to separate urinary and fecal diversion during pelvic exenteration: time to change back?Floor J Backes, Brent J Tierney, Eric L Eisenhauer, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|December 20, 2015
Endometrial Cancer Insulin-Like Growth Factor 1 Receptor (IGF1R) Expression Increases with Body Mass Index and Is Associated with Pathologic Extent and PrognosisAmy S Joehlin-Price, Julie A Stephens, Jianying Zhang, et al.
International Journal of Cancer|October 17, 2019
Guideline-concordant endometrial cancer treatment and survival in the Women's Health Initiative Life and Longevity After Cancer studyAshley S Felix, Eric M McLaughlin, Bette J Caan, et al.
Applied Immunohistochemistry & Molecular Morphology : AIMM|December 20, 2007
The mucin expression profile of endometrial carcinoma and correlation with clinical-pathologic parametersCarl Morrison, Kambiz Merati, William L Marsh, et al.
Gynecologic Oncology|January 12, 2017
HDAC10 as a potential therapeutic target in ovarian cancerMuhtadi M Islam, Tapahsama Banerjee, Colin Z Packard, et al.
Gynecologic Oncology|January 13, 2009
Sequential chemotherapy and irradiation in advanced stage endometrial cancer: A Gynecologic Oncology Group phase I trial of doxorubicin-cisplatin followed by whole abdomen irradiationJeffrey M Fowler, William E Brady, Perry W Grigsby, et al.
Cancer|August 8, 2013
Cost effectiveness of alternative strategies for incorporating bevacizumab into the primary treatment of ovarian cancerJason C Barnett, Angeles Alvarez Secord, David E Cohn, et al.
Frontiers in Genetics|January 28, 2021
Deregulation of a <i>Cis</i>-Acting lncRNA in Non-small Cell Lung Cancer May Control HMGA1 ExpressionGreg L Stewart, Adam P Sage, Katey S S Enfield, et al.
Gynecologic Oncology|November 10, 2015
Treatment strategies for stage IB cervical cancer: A cost-effectiveness analysis from Korean, Canadian and U.S. perspectivesJung-Yun Lee, Janice S Kwon, David E Cohn, et al.
Pageof 31